Table 3.

Ten most frequent first-line chemotherapy regimens by age group^*

< 65 years of age N= 1649		65 years of age and older N= 1809
Carboplatin – Paclitaxel	55.7%	Carboplatin – Paclitaxel	51.1%
Cisplatin – Etoposide	7.7%	Cisplatin – Etoposide	6.4%
Carboplatin – Gemcitabine	4.5%	Carboplatin – Gemcitabine	6.1%
Carboplatin	4.4%	Carboplatin	5.1%
Bevacizumab - Carboplatin – Paclitaxel	4.4%	Carboplatin – Docetaxel	4.3%
Carboplatin – Docetaxel	2.6%	Cisplatin – Gemcitabine	4.3%
Cisplatin – Gemcitabine	2.5%	Erlotinib	2.4%
Erlotinib	2.3%	Carboplatin – Etoposide	2.4%
Carboplatin – Etoposide	1.8%	Vinorelbine	2.3%
Vinorelbine	1.5%	Bevacizumab - Carboplatin –	1.7%
		Paclitaxel
Other Treatment	12.6%	Other Treatment	13.9%

^*Chi-Square difference between proportions: p < 0.0001